Search Results - "KETELSLEGERS, J"

Refine Results
  1. 1

    Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy by Gilson, H, Schakman, O, Combaret, L, Lause, P, Grobet, L, Attaix, D, Ketelslegers, J. M, Thissen, J. P

    Published in Endocrinology (Philadelphia) (01-01-2007)
    “…Glucocorticoids mediate muscle atrophy in many catabolic states. Myostatin expression, a negative regulator of muscle growth, is increased by glucocorticoids…”
    Get full text
    Journal Article Web Resource
  2. 2
  3. 3

    Role of Akt/GSK-3β/β-Catenin Transduction Pathway in the Muscle Anti-Atrophy Action of Insulin-Like Growth Factor-I in Glucocorticoid-Treated Rats by Schakman, O, Kalista, S, Bertrand, L, Lause, P, Verniers, J, Ketelslegers, J. M, Thissen, J. P

    Published in Endocrinology (Philadelphia) (01-08-2008)
    “…Decrease of muscle IGF-I plays a critical role in muscle atrophy caused by glucocorticoids (GCs) because IGF-I gene electrotransfer prevents muscle atrophy…”
    Get full text
    Journal Article
  4. 4

    Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats by Schakman, O, Gilson, H, de Coninck, V, Lause, P, Verniers, J, Havaux, X, Ketelslegers, J. M, Thissen, J. P

    Published in Endocrinology (Philadelphia) (01-04-2005)
    “…Catabolic states caused by injury are characterized by a loss of skeletal muscle. The anabolic action of IGF-I on muscle and the reduction of its muscle…”
    Get full text
    Journal Article
  5. 5

    Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3β signaling pathway by Gruson, D., Ginion, A., Decroly, N., Lause, P., Vanoverschelde, J.L., Ketelslegers, J.M., Bertrand, L., Thissen, J.P.

    Published in Peptides (New York, N.Y. : 1980) (01-07-2010)
    “…Urotensin II (UII) a potent vasoactive peptide is upregulated in the failing heart and promotes cardiomyocytes hypertrophy, in particular through…”
    Get full text
    Journal Article
  6. 6

    Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure by Gruson, D., Lepoutre, T., Ahn, S.A., Ketelslegers, J.M., Rousseau, M.F.

    Published in Clinical biochemistry (01-03-2013)
    “…Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone. Recent evidence has suggested that measurement of PTH might provide complementary…”
    Get full text
    Journal Article
  7. 7

    Circulating urotensin II levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers by Gruson, D., Rousseau, M.F., Ahn, S.A., van Linden, F., Ketelslegers, J.M.

    Published in Peptides (New York, N.Y. : 1980) (01-06-2006)
    “…Urotensin II (UII) is a potent vasoactive cyclic peptide thought to play a role in myocardial hypertrophy and remodelling. We therefore determined UII plasma…”
    Get full text
    Journal Article
  8. 8

    Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure by Gruson, D., Lepoutre, T., Ahn, S. A., Ketelslegers, J. M., Rousseau, M. F.

    Published in Journal of endocrinological investigation (01-12-2012)
    “…Background: PTH is related to left ventricular hypertrophy and its circulating levels are associated with worse prognosis in patients with heart failure (HF)…”
    Get full text
    Journal Article
  9. 9

    Circulating levels of stress associated peptide Urocortin in heart failure patients by Gruson, D., Ahn, S.A., Ketelslegers, J.M., Rousseau, M.F.

    Published in Peptides (New York, N.Y. : 1980) (01-02-2010)
    “…The available data suggest that Urocortin (UCN), a cardioprotective and vasoactive peptide known from fish neuroendocrinology, is involved in cardiac…”
    Get full text
    Journal Article
  10. 10

    Expression of the serotonin 1b receptor in experimental pulmonary hypertension by Rondelet, B, Van Beneden, R, Kerbaul, F, Motte, S, Fesler, P, McEntee, K, Brimioulle, S, Ketelslegers, J-M, Naeije, R

    Published in The European respiratory journal (01-09-2003)
    “…The pathogenesis of pulmonary arterial hypertension (PAH) remains uncertain. Both the serotonin and endothelin (ET) systems are believed to be involved. Recent…”
    Get full text
    Journal Article
  11. 11

    Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children by Ninh, NX, Thissen, JP, Collette, L, Gerard, G, Khoi, HH, Ketelslegers, JM

    Published in The American journal of clinical nutrition (01-04-1996)
    “…To determine whether zinc deficiency might be involved in the failure to thrive observed in undernourished Vietnamese children, we assessed growth, incidence…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Regulation of insulin-like growth factor-I in starvation and injury by Thissen, J.P, Underwood, L.E, Ketelslegers, J.M

    Published in Nutrition reviews (01-06-1999)
    “…Both starvation and sepsis are characterized by growth hormone (GH) insensitivity, which leads to a reduction in circulating insulin-like growth factor…”
    Get full text
    Journal Article
  13. 13

    Nutritional regulation of insulin-like growth factor-I by Ketelslegers, Jean-Marie, Maiter, Dominique, Maes, Marc, Underwood, Louis E., Thissen, Jean-Paul

    Published in Metabolism, clinical and experimental (01-10-1995)
    “…Several lines of evidence indicate that in the human, insulin-like growth factor-I (IGF-I) is nutritionally regulated. Both energy and protein availability are…”
    Get full text
    Journal Article Conference Proceeding
  14. 14
  15. 15

    Reduced liver insulin-like growth factor-I gene expression in young zinc-deprived rats is associated with a decrease in liver growth hormone (GH) receptors and serum GH-binding protein by Ninh, N X, Thissen, J P, Maiter, D, Adam, E, Mulumba, N, Ketelslegers, J M

    Published in Journal of endocrinology (01-03-1995)
    “…Zinc depletion attenuates growth and decreases circulating IGF-I. To investigate the mechanisms responsible for the IGF-I decline, we determined the effects of…”
    Get more information
    Journal Article
  16. 16

    Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension by RONDELET, Benoit, KERBAUL, Francois, NAEIJE, Robert, MOTTE, Sophie, VAN BENEDEN, Ronald, REMMELINK, Myriam, BRIMIOULLE, Serge, MCENTEE, Kathleen, WAUTHY, Pierre, SALMON, Isabelle, KETELSLEGERS, Jean-Marie

    Published in Circulation (New York, N.Y.) (11-03-2003)
    “…The dual endothelin-receptor antagonist bosentan has been reported to improve pulmonary arterial hypertension, but the role of endothelins in the pathogenesis…”
    Get full text
    Journal Article
  17. 17

    Reference values of IGF-I in children from birth to 5 years of age, in Burkina Faso, using blood samples on filter paper by Kouanda, S, Tonglet, R, De Coninck, V, Doulougou, B, Sondo, B, Ketelslegers, J.M, Robert, A

    Published in Growth hormone & IGF research (01-08-2008)
    “…Abstract Objectives The aims of this study were to validate the use of filter paper to measure insulin-like growth factor-I (IGF-I) and to establish normal…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats by Maiter, D, Underwood, L E, Maes, M, Davenport, M L, Ketelslegers, J M

    Published in Endocrinology (Philadelphia) (01-08-1988)
    “…To determine if the pattern of GH delivery is important for the regulation of serum somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) and liver…”
    Get more information
    Journal Article
  20. 20

    Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle by VandeHaar, M J, Moats-Staats, B M, Davenport, M L, Walker, J L, Ketelslegers, J M, Sharma, B K, Underwood, L E

    Published in Journal of endocrinology (01-08-1991)
    “…The serum concentration of insulin-like growth factor-I (IGF-I) is reduced in growing rats fed a low-protein diet, and this decrease is age-dependent, being…”
    Get more information
    Journal Article